NCT05853055 (Fatignals) is a NA clinical trial of Respiratory training in Post-COVID-19 Related Fatigue, sponsored by Simon Annaheim.

Who is sponsoring NCT05853055?

NCT05853055 is sponsored by Simon Annaheim.

What drugs are being tested in NCT05853055?

Interventions in NCT05853055: Respiratory training.

What condition does NCT05853055 study?

NCT05853055 studies Post-COVID-19 Related Fatigue.

Is NCT05853055 still recruiting?

NCT05853055 is currently completed. Last updated 13 January 2025.

Last reviewed 2025-01-13 · How we verify

NCT05853055: Fatignals

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Disease-related Fatigue Monitoring Based on Body Signals Measured on the Skin

Completed NA Last updated 13 January 2025

What this trial tests

NA trial testing Respiratory training in Post-COVID-19 Related Fatigue in 33 participants. Completed in 12 July 2024.

Timeline

9 February 2023

Primary endpoint
12 July 2024

12 July 2024

Quick facts

Lead sponsor	Simon Annaheim
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	other
Enrollment	33
Start date	9 February 2023
Primary completion	12 July 2024
Estimated completion	12 July 2024
Sites	1 location across Switzerland

Drugs / interventions tested

Respiratory training

Conditions studied

Post-COVID-19 Related Fatigue — all drugs for Post-COVID-19 Related Fatigue →

Sponsor

Simon Annaheim

Who can join

18 and older, any sex, with Post-COVID-19 Related Fatigue. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study investigates the use of physiological parameters as predictors of disease-related fatigue. For that purpose, wearable devices are used to monitor post-COVID-19 patients during their stay in a rehabilitation clinic. Besides, the effectiveness of respiratory training in reducing breathlessness and improving exercise breathing patterns in patients suffering from post-COVID-19 will be explored.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Respiratory training

Trials testing the same drug.

NCT06312319 — Home-based Respiratory Training on Swallowing in Stroke · NA · unknown

Other Simon Annaheim trials

Trials by the same sponsor.

NCT06425068 — Assessment of an Innovative Air Mattress on Critically Ill Infants · NA · completed
NCT04650776 — Non-invasive Prediction of Thermal Strain in Healthy Male Adults · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05853055 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Simon Annaheim
Last refreshed: 13 January 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05853055.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing